News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Esperion Therapeutics Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioMidwest
If Investors Like Merck & Co.'s Zetia Results, They Will Love Esperion Therapeutics, Inc.’s, Says Citi
November 17, 2014
·
1 min read
BioMidwest
Citi: Esperion Therapeutics, Inc. Will See Cancer Drug Data By End Of Year
November 11, 2014
·
1 min read
Pharm Country
The New Cholesterol
October 19, 2005
·
1 min read
Business
Pfizer In Wings For Star HDL-Cholesterol Role
October 19, 2005
·
1 min read
Cholesterol Treats Heart Disease; Potential Heart Disease Breakthrough
October 19, 2005
·
1 min read
Defending Esperion
October 19, 2005
·
1 min read
Deals
Top 2003 Stories From The BioSpace NewsBeat
October 19, 2005
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
/C O R R E C T I O N -- HLS Therapeutics Inc./
March 5, 2026
·
7 min read
Press Releases
HLS Therapeutics Announces NILEMDO™ (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease
March 5, 2026
·
6 min read
Press Releases
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
March 3, 2026
·
11 min read
Press Releases
HLS Therapeutics Announces Health Canada Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease
November 19, 2025
·
6 min read
BioMidwest
Esperion to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 7, 2020
·
6 min read
Policy
Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors
April 24, 2019
·
1 min read
Business
Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe
January 4, 2019
·
8 min read
Business
Retrophin Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
September 17, 2018
·
4 min read
Deals
Free Technical Research Reports on Biotech Stocks -- Epizyme, Esperion Therapeutics, Exelixis, and Grifols
July 27, 2018
·
7 min read
Drug Development
Esperion Announces Third Pivotal Phase 3 Study of Bempedoic Acid Meets Primary Endpoint
May 23, 2018
·
13 min read
